Carna Health | $8,000,000 | (Jan 9, 2026)
Corsera Health | $80,000,000 | (Jan 9, 2026)
Oasys | $4,600,000 | (Jan 9, 2026)
FluoRok
United Kingdom
- Oxford, England
- 24/09/2024
- Unknown
- $10,298,480
We are a VC-backed spin-out of the University of Oxford reinventing the way fluorochemicals are produced. Fluorochemicals are fundamental to our daily lives (agrochemicals, marketed drugs, anesthetics, polymers & materials) and we are developing disruptive fluorinating technologies that are safe, efficient and sustainable for a cleaner planet and a brighter future. Co-founded by Prof. V Gouverneur and Dr G. Pupo, Fluorok’s mission is to find new solutions to improve people’s health and food availability while reducing our impact on the planet.
- Industry Chemical Manufacturing
- Website https://www.fluorok.com/
- LinkedIn https://www.linkedin.com/company/fluorok/
Related People
Gabriele PupoFounder
United Kingdom -
Yarnton, England
We are a VC-backed spin-out of the University of Oxford reinventing the way fluorochemicals are produced. Fluorochemicals are fundamental to our daily lives (agrochemicals, marketed drugs, anesthetics, polymers & materials) and we are developing disruptive fluorinating technologies that are safe, efficient and sustainable for a cleaner planet and a brighter future. Co-founded by Prof. V Gouverneur and Dr G. Pupo, Fluorok’s mission is to find new solutions to improve people’s health and food availability while reducing our impact on the planet.
Poplar Therapeutics | $50,000,000 | (Jan 9, 2026)
Alveus Therapeutics Inc | $160,000,000 | (Jan 9, 2026)
AgileRL | $7,500,000 | (Jan 9, 2026)
Soley Therapeutics | $200,000,000 | (Jan 9, 2026)
Array Labs | $20,000,000 | (Jan 7, 2026)
CHAMP | $55,000,000 | (Jan 7, 2026)
Lemon Slice | $10,500,000 | (Jan 7, 2026)
Tesoro XP, Inc. | $5,400,000 | (Jan 7, 2026)
Coinbax | $4,200,000 | (Jan 7, 2026)